Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

This case study reports on a 13-year-old male with alopecia totalis who experienced successful hair regrowth after being treated with dupilumab, an interleukin-4 and IL-13 antagonist, suggesting its potential utility in managing alopecia areata in pediatric patients with comorbid atopic dermatitis.

This study found that administering botulinum toxin A via Flex-PADs to mouse footpads inhibited sweating similarly to traditional injections, suggesting a promising patient-friendly delivery method for hyperhidrosis treatment.

This report highlights two cases where patchy alopecia developed after mesotherapy for androgenetic alopecia, indicating potential risks associated with this treatment.

This study found that trichoscopy can rapidly and noninvasively diagnose tinea capitis and alopecia areata in pediatric patients by identifying specific hair patterns associated with each condition.

This research analyzed 72 primary scarring alopecia cases in a Barcelona hospital, finding that the majority involved women, with a lymphocytic infiltrate and subacute onset in many cases, leading to stable disease, while neutrophilic cases had more acute episodes.

This study found that platelet-rich plasma treatment increased hair density and reduced inflammation in patients with patchy alopecia areata, but not in a patient with alopecia universalis.

This case report describes an 18-year-old female with alopecia areata who experienced hair regrowth within seven days following Prachana Vidhi treatment in an Ayurvedic setting, suggesting this approach may offer effective results for patchy hair loss.

In this case study, an 8-year-old girl with alopecia areata showed hair regrowth in patches following homeopathic treatment, suggesting a positive response to this therapeutic approach.

In this study, an 18-year-old boy with alopecia areata successfully experienced normal and healthy hair regrowth after 4 months using microneedling with cupping, alongside internal herbal medication and topical oil application, as a cost-effective and less invasive alternative to high-cost hair treatments and transplantation.

This case study suggests that Ayurvedic treatment, including Karanj oil, herbal churna, and leech therapy, provided significant hair regrowth in a 16-year-old with alopecia areata after three months, despite previous unsuccessful conventional medicine treatments.

A synthetic drug and a South American herb may help treat alopecia areata in Chinese men.

This review discusses rodent models of alopecia areata and suggests they are crucial for understanding the autoimmune mechanisms and potential treatments but reports no new clinical results.

This article discusses tissue-expansion augmented scalp reduction as a surgical option for cicatricial alopecia patients who are otherwise not candidates for traditional hair replacement techniques, but it reports no new clinical results.

This article discusses the minimal research on hair growth physiology and highlights Dr. Masumi Inaba's contributions to understanding androgenetic alopecia, but reports no new experimental results.

This article reviews hair and nail disorders in children, emphasizing their prevalence, congenital and acquired origins, and the diagnostic challenges compared to treatment, but reports no new clinical results.

This study reported that a curcumin-zinc microneedle patch improved hair regrowth and wound healing in animal models, suggesting potential as a versatile treatment for hair loss.

This article discusses the perspectives of Western and Chinese medicine on alopecia areata and proposes that blood stasis may be a key factor, recommending treatments focused on blood circulation.

This study, conducted among Egyptians, found a borderline significant association between the Stul polymorphism of the androgen receptor gene and androgenetic alopecia in males, with higher androgen receptor expression in balding scalp areas.

This review outlines various causes and manifestations of hair loss, highlighting that each type has distinct underlying mechanisms and requires specific treatment approaches, without reporting new clinical results.

This case report suggests that an Ayurvedic treatment protocol may effectively manage paediatric indralupta, a condition similar to alopecia areata, with complete hair restoration observed in an 11-year-old patient without adverse effects.

In this study, minoxidil 2% solution was more effective than tacrolimus 0.1% ointment for promoting hair regrowth in mild to moderate patchy alopecia areata.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

The abstract does not provide any specific research findings or results, but rather serves as a promotional description for IP Innovative Publication Pvt Limited, highlighting their services and publication offerings in medical journals and related fields from Delhi, India.

This review discusses the pathophysiology of alopecia areata, highlighting the role of CD8 cytotoxic T cells and the upregulation of JAK signaling pathways; it reports no new experimental results.

Women with thinning hair have thinner hair strands than women without hair loss.

This review discusses the role of stem cells in alopecia pathogenesis, highlighting the differences between scarring and nonscarring types, and reports no new clinical results.

This review summarizes preclinical and clinical information on herbal products for hair loss treatment, highlighting their mechanisms, follicular penetration, and potential side effects, suggesting they may offer alternatives to synthetic drugs with fewer side effects.

This study found that diphencyprone showed a significant clinical response for treating alopecia areata, while tacrolimus was not effective.